Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People
Conclusions: Younger patients and those with co-occurring substance use remain at higher risk of discontinuing buprenorphine/naloxone treatment for OUD in this population of ANAI people. Treatment programs serving ANAI people may consider paying special attention to patients with these characteristics to prevent treatment discontinuation. Our study highlights the need to address poly-substance use among ANAI people in treatment. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Original Research Source Type: research

The Use of Once-monthly Injectable Buprenorphine for the Treatment of Opioid Use Disorder in Postpartum Women: A Case Series
Conclusions: To our knowledge, this is the first study that reviews the feasibility of using XRI-BUP in postpartum women. Our results suggest that XRI-BUP is a viable treatment option, which should be further investigated in future studies of postpartum women with OUD. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Original Research Source Type: research

Civil Commitment for Substance Use Disorders: A National Survey of Addiction Medicine Physicians
Background: Civil commitment (CC) for substance use disorders (SUDs) is a legal mechanism, initiated by family members, healthcare professionals, or others, that compels individuals with substance use problems into involuntary treatment. With the recent rise of US overdose deaths, more states are considering these laws. Yet little is known about physicians’ perspectives regarding CC in treating patients with SUDs. Methods: We conducted a web-based survey of American Society of Addiction Medicine (ASAM) physician members regarding their awareness of, attitudes towards, and experiences with CC for adults with SU...
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Original Research Source Type: research

Commentary on “Civil Commitment for SUDs: A National Survey of Addiction Medicine Physicians”
In this issue, authors Abhishek Jain and colleagues report the outcome of a survey of the physician membership of the American Society of Addiction Medicine, bearing on attitudes toward the use of civil commitment in the treatment of substance use disorders (SUDs). This comment considers the sources of the pejorative view in which civil commitment for SUD is often held, identifying several historical analogies with other illnesses. Resolution of the common confusion between toxidrome and addiction, with a renewed emphasis on the treatability of SUDs, may contribute to more productive treatment matching and outcomes. (Sourc...
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Commentaries Source Type: research

Involuntary Commitment for Substance Use: Addiction Care Professionals Must Reject Enabling Coercion and Patient Harm
This study distributed a web-based survey to physician-members of the American Society of Addiction Medicine with questions gauging awareness of, attitudes toward, and experiences with civil commitment for individuals with substance use disorder. Surprisingly, the study found that the overwhelming majority of addiction medicine providers supported the application of civil commitment for substance use disorder—60.7% reported being in favor of its use whereas only 21.5% reported being opposed. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Commentaries Source Type: research

Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic: Providers’ Leadership Efforts in Unprecedented Times
Opioid use disorder (OUD) is an unprecedented medical and public health issue both in Puerto Rico (PR) and the greater US with an increase incidence of opioid use every year. Unprecedented and compounded emergencies in PR such as those caused by hurricanes, earthquakes, and the COVID-19 pandemic coupled with limited national and local governmental support, has forced most clinics in PR to take action to be able to continue providing care. This commentary summarizes the leadership and clinical initiatives of 3 community organizations in PR to maintain services for people with OUD during the COVID-19 pandemic. Local legislat...
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Commentaries Source Type: research

DEA Disconnect Leads to Buprenorphine Bottlenecks
Conclusions: We recommend Drug Enforcement Administration policy clarifications or changes to facilitate distributor interpretation; pharmacist workflow; and patient access to medication. We also advise continuing education with pharmacists and buprenorphine prescribers. These steps would facilitate greater access to lifesaving treatment for opioid use disorder. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Commentaries Source Type: research

A Bridge Too Far: Individuals With Regular and Increasing Very Heavy Alcohol Consumption Cannot be Considered as Maintaining “Recovery” Due to Toxicity and Intoxication-related Risks
The concept of “recovery” from alcohol use disorders (AUD) has garnered increasing scientific interest in recent years including attempts to explicate and measure its presumed component parts. In general, there is consensus that “recovery” should not be solely about abstinence or quantity-frequency measures of alcohol consumption and should include measures of functioning. Some researchers have taken an even more radical step, however, to suggest that psychosocial functioning should be the sine qua non defining feature of “recovery,” seemingly irrespective of how much one drinks; as such, people can be classifi...
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Commentaries Source Type: research

Postpartum Treatment of Individuals With Opioid Use Disorder: Maternal Risk and Need for Evidence Do Not End When Pregnancy Ends
No abstract available (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - July 1, 2021 Category: Addiction Tags: Editorial Source Type: research

Rapid Transition of Individual and Group-based Behavioral Outpatient Visits to Telepsychiatry in Response to COVID-19
No abstract available (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - May 1, 2021 Category: Addiction Tags: Letters to the Editor Source Type: research

Barriers and Facilitators to Providing HIV Preexposure Prophylaxis Among Buprenorphine Prescribers: A Pilot Qualitative Study
No abstract available (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - May 1, 2021 Category: Addiction Tags: Letters to the Editor Source Type: research

Imaging in Vaping-associated Lung Injury: Beyond the Haze
E-cigarette or vaping, product associated lung injury is a rampant public health issue with a total of 2807 reported hospitalized patients in the United States as of February 18, 2020. Limited data, non-specific symptoms, non-responsiveness to antibiotics, and the lack of a specific biomarker, make it a diagnosis of exclusion. Overlap of clinical and imaging findings with other ongoing respiratory illness (MERS, SARS and COVID-19) poses a challenge in accurate diagnosis. We compiled 3 cases of patients hospitalized with confirmed vaping-associated lung injury and analyzed their imaging patterns, which revealed bilateral co...
Source: Journal of Addiction Medicine - May 1, 2021 Category: Addiction Tags: Case Reports Source Type: research

Hospital-based Buprenorphine Micro-dose Initiation
We report a novel strategy for hospital-based low-dose buprenorphine initiation that facilitates transition from full opioid agonists to buprenorphine. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - May 1, 2021 Category: Addiction Tags: Case Reports Source Type: research

Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series
We report on three cases of successful transition from low dose sublingual buprenorphine to a single injection of 100 mg extended-release buprenorphine to opioid cessation in patients who had previously been unable to taper fully off buprenorphine. This novel use of extended-release buprenorphine provides a viable alternative to fully transition patients off buprenorphine when they are medically and emotionally ready. (Source: Journal of Addiction Medicine)
Source: Journal of Addiction Medicine - May 1, 2021 Category: Addiction Tags: Case Reports Source Type: research

Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report
In the last 2 decades, there is a renaissance in the scientific investigation of the therapeutic potential of psychedelic compounds. It is studied for the treatment of many psychiatric disorders, including posttraumatic stress disorder. The treatment is always done in the setting of psychedelic-assisted psychotherapy. A little is known about the potential effects, outside of the setting of psychedelic-assisted psychotherapy, on people diagnosed with a mental disorder or have a significant trauma history. In this case report, we present a young man who developed posttraumatic stress disorder after a psychedelic experience, ...
Source: Journal of Addiction Medicine - May 1, 2021 Category: Addiction Tags: Case Reports Source Type: research